Cappella Medical Devices, Ltd. Company Profile
Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappellaâs initial product, the Sideguard® Coronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating the sidebranch of diseased coronary arteries first, rather than the main vessel. It allows the clinicianâs preferred stent of choice to then be placed in the main vessel. The Sideguard® system combines a proprietary split-sheath technology delivery system that ensures precise placement with a unique trumpet-shape self expanding nitinol design that protects the ostium and promotes continuous wall apposition and positive remodeling. In addition, a new second radio-opaque marker has been added to the catheter as a reference point when visualizing under angiography to help facilitate proper positioning on the ostial borderline. Cappella Medical Devices Ltd., Galway, Ireland is the R&D and manufacturing subsidiary of Cappella, Inc. For more information, please visit the Cappella Medical Systems website at www.cappella-med.com.
News Articles
Cappella Medical Devices Ltd (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, today announced the multic...
MALIBU, Calif., May 9, 2013 (GLOBE NEWSWIRE) -- More than 600 singers and advocates of a cappella music will converge on Malibu, California this week for a distinctive and eclectic festival dedicated...
Dallas, Texas (PRWEB) May 04, 2013 Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market looks at the regulatory landscape and reimbursement scenario in the US for fou...
How can we get high quality routine data to monitor the safety of devices and procedures?
Difficulties with medical devices and discussions at the European Commission about new regulations have focused attention on how to introduce devices and procedures safely.1 2 Both medical devices......
U.S. FDA urges protection of medical devices from cyber threats
June 13 (Reuters) - The U.S. Food and Drug Administration, citing potential cyber threats to medical devices, on Thursday urged medical device makers, hospitals and other medical facilities to upgrade...
Gloomy Prospects For Medical Device Companies
By Ron Sommer: The medical device industry confronts several challenges that will have long-term implications. Revenue in this industry will not grow as quickly over the next five years and the incre...
SINGAPORE, Dec. 10, 2012 /- The medical devices distribution market in Vietnam, Indonesia, Thailand, and South Korea (VITSK) is highly fragmented, with 1428 distributors in Vietnam alone. This is due...
Making Medical Devices Safer at Home
Today, medical devices are often used at home,enabling people with medical conditions to lead full, active lives. However, consumers using them face many challenges. FDA is working to make these devic...
Drugs and Medications
Alcohol [Dalian Rongbang Medical Helathy Devices Co]
Alcohol Swabsticks
Alcohol prep pad [Dalian Rongbang Medical Healthy Devices]
Alcohol Prep Pad
Anticoagulant Citrate Dextrose Solution USP (ACD) Solution A 750 ml
Povidone iodine [Dalian Rongbang Medical Healthy Devices Co]
Povidone Iodine Pad
Drug Facts
PubMed Articles
Use of the Sideguard (Cappella) stent in bifurcation lesions: a real-world experience.
Aims: The Sideguard® stent (Cappella Medical Devices Ltd, Galway, Ireland), is a novel nitinol self-expanding dedicated bifurcation stent that flares proximally at the ostium of the side branch (SB)...
How medical devices are regulated in the UK.
Excluding medicines, most other healthcare products are medical devices.1 It is estimated that around 38 million people in the UK "have contact with" a medical device every day,2 and there are more th...
The 4th amendment of the Medical Device Law introduced the authorization procedure for clinical trials with medical devices. The Federal Institute for Drugs and Medical Devices ("Bundesinstitut für A...
Reusable invasive medical devices: clean and prepare.
In England, there are approximately 170 NHS hospitals managed by acute trusts, where over 4.2million surgical procedures are performed annually (NHS, 2012; Royal College of Surgeons, 2012). The majori...
Biomaterials in medical devices: An Interview with Jörg Vienken of Fresenius Medical Care, Germany.
Biomaterial and biopolymer research have significant impact on the development as well as application of biotechnology. Biotechnology Journal recently attended the "Nanomaterials for Biomedical Techno...
Clinical Trials
Assessment of Myocardial Disease in Man Using Novel Non-invasive Diagnostic Tools
This study will be testing two devices which are designed to detect cardiovascular disease in patients as early as possible. As there are now many therapies to prevent and treat this cond...
Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
RATIONALE: Gathering information about patients with solid tumors who have implantable venous access devices may help doctors learn more about patient satisfaction. PURPOSE: This phase I...
Safety of Catheter Lock With or Without Heparin in Implanted Central Venous Catheters
Long-term central venous access devices are considered as safe for the administration of medication as chemotherapy, but are also used for blood sampling. For years these catheters have be...
This research includes the evaluation of a checklist and on-site screening devices to pre-select drivers suspected of being drug-impaired. The reliability of a limited number of promising...
ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion
The rise of minimal access surgery has heralded the approval of a number of endovascular devices with similar indications. This is particularly true for the treatment of lower extremity is...
Companies
Cappella, Inc. is a medical device company that develops novel solutions for the treatment of complex coronary artery disease (CAD) focused on protecting the coronary sidebranch a...
Cappella Medical Devices Limited
Cappella, Inc. develops novel solutions for the treatment of complex coronary artery disease (CAD) - specifically bifurcation disease. Cappellaâs Sideguard® coronary sideb...
Cappella Medical Devices, Ltd.
Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Ca...
Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD), specifically bifurcation disease. Cappellaâ...
Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappella's initial prod...
More Information about "Cappella Medical Devices, Ltd." on BioPortfolio
We have published hundreds of Cappella Medical Devices, Ltd. news stories on BioPortfolio along with dozens of Cappella Medical Devices, Ltd. Clinical Trials and PubMed Articles about Cappella Medical Devices, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cappella Medical Devices, Ltd. Companies in our database. You can also find out about relevant Cappella Medical Devices, Ltd. Drugs and Medications on this site too.
